drugset / Trial / NCT00328939

ARIXTRA Local Study For Registration In China.

NCT00328939

Phase 3 Completed 240 enrolled GlaxoSmithKline
RandomizedParallel-groupSingle-blindPrevention

Summary

This is a local registration study in China to compare the safety and efficacy of ARIXTRA to Enoxaparine in patients undergoing elective major hip or knee replacement or a revision of components.

Timeline

Start
2004-05
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Enoxaparin sodium Other / unclassified
Subject Fondaparinux Other / unclassified